NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Only one other trial with a combination therapy as Dr. Liau was able to get NIH funding from one of the many GBM therapies being tested. Notice Merck has seen DCVax-L data and they have not bought in while they are buying other biotechs. If the data was that good, Merck would certainly be interested -- but not

Let's see if NWBO can keep the lights on after a couple of more years waiting for data, and until 2024 until FDA can possibly come to a decision on DCVax-L. A lot of debt to cover next year to payoff LP's Advent debts for her.